Basanta M, Ibrahim B, Dockry R, Douce D, Morris M, Singh D, Woodcock A, Fowler SJ. (2012). Exhaled volatile organic compounds for phenotyping chronic obstructive pulmonary disease: a cross-sectional study. Respiratory Research, 13(1), 72. eScholarID:179258 | DOI:10.1186/1465-9921-13-72
Ibrahim B, Marsden P, Morris J, Smith J, Nilsson M, Fowler SJ. (2012). Metabolomic Analysis of Exhaled Breath Condensate by NMR Spectroscopy Discriminates Inflammatory Phenotypes in Asthma. eScholarID:144840
Basanta M, Ibrahim B, Douce D, Morris M, Woodcock A, Fowler SJ. (2012). Methodology validation, intra-subject reproducibility and stability of exhaled volatile organic compounds. eScholarID:144842
Basanta M, Ibrahim B, Douce D, Morris M, Woodcock A, Fowler SJ. (2012). Methodology validation, intra-subject reproducibility and stability of exhaled volatile organic compounds. Journal of Breath Research, 6, 026002. eScholarID:179259 | DOI:10.1088/1752-7155/6/2/026002
2011
Maria Basanta, Baharudin Ibrahim, Rachel Dockry, David Douce, Mike Morris, Dave Singh, Ashley Woodcock, Stephen J. Fowler. (2011). Exhaled Volatile Organic Compounds for Phenotyping Chronic Obstructive Pulmonary Disease. eScholarID:127623
Ibrahim B, Basanta M, Cadden P, Singh D, Douce D, Woodcock A, Fowler SJ. (2011). Non-invasive phenotyping using exhaled volatile organic compounds in asthma. Thorax, doi:10.1136/thx.2010.156695. eScholarID:127622 | DOI:10.1136/thx.2010.156695
2010
Basanta, M., Jarvis, R., Xu, Y., Blackburn, G., Tal-Singer, R., Woodcock, A., Singh, D., Goodacre, R., Thomas, C. & Fowler, S (2010). Non-invasive metabolomic analysis of breath using differential mobility spectrometry in patients with chronic obstructive pulmonary disease and healthy smokers. Analyst, 135(2), 315-20. eScholarID:79581 | PMID:20098764 | DOI:10.1039/b916374c
2009
Fowler SJ, Langley SJ, Truman NJ, Simpson A, Woodcock AA, Custovic A. (2009). The long term effects of allergen sensitization and exposure in adult asthma: a prospective study. World Allergy Organization Journal, 2, 83-90. eScholarID:8202 | DOI:10.1097/WOX.0b013e3181a45f96
2008
John Firth, Paul Roberts, Stephen Fowler. (Ed.) (2008). Medical Masterclass. Royal College of Physicians of London. eScholarID:8116
(2008). Multiple Chapters. In John Firth, Paul Roberts, Stephen Fowler (Ed.), Medical Masterclass. (pp. -). Royal College of Physicians of London. eScholarID:8135
(2008). Respiratory System. In John Firth (Ed.), Medical Masterclass. (pp. -). Royal College of Physicians of London. eScholarID:8150
2007
Basanta M, Singh D, Fowler S, Wilson I, Dennis R, Thomas CL. (2007). Increasing analytical space in gas chromatography-differential mobility spectrometry with dispersion field amplitude programming. Journal of chromatography A, 1173, 129-138. eScholarID:8159
2006
Fowler SJ, French J, Screaton N, Foweraker J, Condliffe A, Haworth C, Exley A, Bilton D. (2006). Nontuberculous mycobacteria in bronchiectasis: prevalence and patient characteristics. Eur Respir J, 28( 6), 1204-10. eScholarID:1d30600
2003
Currie G, Lee D, Dempsey O, Fowler SJ, Cowan L, Lipworth B. (2003). A proof of concept study to evaluate putative benefits of montelukast in moderate persistent asthmatics. Br J Clin Pharmacol, 55( 6), 609-15. eScholarID:1d30137
Currie G, Fowler SJ, Lipworth B. (2003). Dose response of inhaled corticosteroids on bronchial hyperresponsiveness: a meta-analysis. Ann Allergy Asthma Immunol, 90( 2), 194-8. eScholarID:1d30221
Currie G, Haggart K, Lee D, Fowler SJ, Wilson A, Brannan J, Anderson S, Lipworth B. (2003). Effects of mediator antagonism on mannitol and adenosine monophosphate challenges. Clin Exp Allergy, 33( 6), 783-8. eScholarID:1d12405 | DOI:10.1046/j.1365-2222.2003.01688.x
Orr L, Fowler SJ, Lipworth B. (2003). Relationship between changes in quality of life and measures of lung function and bronchial hyper-responsiveness during high-dose inhaled corticosteroid treatment in uncontrolled asthma. Am J Respir Med, 2( 5), 433-8. eScholarID:1d30018
Fowler SJ, Lipworth B. (2003). Relationship of skin-prick reactivity to aeroallergens and hyperresponsiveness to challenges with methacholine and adenosine monophosphate. Allergy, 58( 1), 46-52. eScholarID:1d12406 | DOI:10.1034/j.1398-9995.2003.23779.x
2002
Fowler SJ, Hall I, Wilson A, Wheatley A, Lipworth B. (2002). 5-Lipoxygenase polymorphism and in-vivo response to leukotriene receptor antagonists. Eur J Clin Pharmacol, 58( 3), 187-90. eScholarID:1d30794
Currie G, Fowler SJ, Wilson A, Sims E, Orr L, Lipworth B. (2002). Airway and systemic effects of hydrofluoroalkane fluticasone and beclomethasone in patients with asthma. Thorax, 57( 10), 865-8. eScholarID:1d30228
Dempsey O, Fowler SJ, Wilson A, Kennedy G, Lipworth B. (2002). Effects of adding either a leukotriene receptor antagonist or low-dose theophylline to a low or medium dose of inhaled corticosteroid in patients with persistent asthma. Chest, 122( 1), 151-9. eScholarID:1d30577
Fowler SJ, Currie G, Lipworth B. (2002). Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone. J Allergy Clin Immunol, 109( 6), 929-35. eScholarID:1d12408 | DOI:10.1067/mai.2002.123869
Fowler SJ, Orr L, Sims E, Wilson A, Currie G, McFarlane L, Lipworth B. (2002). Therapeutic ratio of hydrofluoroalkane and chlorofluorocarbon formulations of fluticasone propionate. Chest, 122( 2), 618-23. eScholarID:1d12407
2001
Fowler SJ, Wilson A, Griffiths E, Lipworth B. (2001). Comparative in vivo lung delivery of hydrofluoroalkane-salbutamol formulation via metered-dose inhaler alone, with plastic spacer, or with cardboard tube. Chest, 119( 4), 1018-20. eScholarID:1d29916
Fowler SJ, Orr L, Wilson A, Sims E, Lipworth B. (2001). Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate. Br J Clin Pharmacol, 52( 1), 93-5. eScholarID:1d31209
Wilson A, Fowler SJ, Martin S, White P, Gardiner Q, Lipworth B. (2001). Evaluation of the importance of head and probe stabilisation in acoustic rhinometry. Rhinology, 39( 2), 93-7. eScholarID:1d30795
Fowler SJ, Lipworth B. (2001). Pharmacokinetics and systemic beta2-adrenoceptor-mediated responses to inhaled salbutamol. Br J Clin Pharmacol, 51( 4), 359-62. eScholarID:1d29915
Fowler SJ, Lipworth B. (2001). Salmeterol and inhaled corticosteroids in patients with persistent asthma. JAMA, 286( 24), 3076-7; author reply 3077-8. eScholarID:1d30573
2000
Fowler SJ, Dempsey O, Sims E, Lipworth B. (2000). Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate. Relationship to asthma severity and beta(2)-receptor genotype. Am J Respir Crit Care Med, 162( 4 Pt 1), 1318-22. eScholarID:1d30085